Cargando…

Management of multidrug-resistant TB: novel treatments and their expansion to low resource settings

Despite overall progress in global TB control, the rising burden of multidrug-resistant TB (MDR-TB) threatens to undermine efforts to end the worldwide epidemic. Of the 27 countries classified as high burden for MDR-TB, 17 are in ‘low’ or ‘low–middle’ income countries. Shorter, all oral and less tox...

Descripción completa

Detalles Bibliográficos
Autores principales: Sloan, Derek J., Lewis, Joseph M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755422/
https://www.ncbi.nlm.nih.gov/pubmed/26884496
http://dx.doi.org/10.1093/trstmh/trv107